The optimal management of patients with diabetes is a multifaceted issue that requires the concomitant control of blood pressure, glycemic, HbA1c, and lipid levels. While accomplishing those goals may further reduce mortality by an additional 40-60%, less than 10% of the population is able to achieve those modest profiles. Populations that tend to struggle with achieving optimal outcomes are those who are “non-engaged”, perhaps due to personal limitations and/or the lack of resources. The latter is especially notable because, unfortunately, access to care, necessary medications, and beneficial lifestyle modifications are all expensive as well. Furthermore, T2DM rarely travels alone, and the pill burden that is associated with concurrent management of multiple comorbid conditions is frequently taxing to patients.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
RFK Jr Claims HHS Has Not Fired Working Scientists, Canceled Lifesaving Research
May 15th 2025Robert F. Kennedy Jr’s congressional hearing featured numerous statements from the secretary of HHS, including denouncing claims of cutting down the HHS and the National Institutes of Health.
Read More
Trump Administration Walks Back Mental Health Parity in Insurance Coverage
May 13th 2025The Trump administration has decided to further debate the federal rule passed during the Biden administration that guaranteed insurance coverage for treatment of mental illness and substance abuse.
Read More